Using various cell surface markers, including GITR, they distinguished Tregs from other activated T cells and observed an increase in Tregs expression levels in both peripheral blood and tumor tissue of HCC patients, providing a finding that correlates with the evidence previously described herein. The gene discussed is TNFRSF18; the disease is hepatocellular carcinoma.